Cargando…

MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours

BACKGROUND: miRNAs are small noncoding RNA molecules that can be released into body fluids. Germ cell tumours (GCTs) overexpress miRNAs of the miR-371-3 cluster. Thus, serum levels of these miRNAs may correlate with tumour load. METHODS: miRNAs of the miR-371-3 cluster were quantified in cubital vei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dieckmann, K-P, Spiekermann, M, Balks, T, Flor, I, Löning, T, Bullerdiek, J, Belge, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493876/ https://www.ncbi.nlm.nih.gov/pubmed/23059743 http://dx.doi.org/10.1038/bjc.2012.469

Ejemplares similares

MicroRNA-371a-3p—The Novel Serum Biomarker in Testicular Germ Cell Tumors
por: Nestler, Tim, et al.
Publicado: (2023)

Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin
por: Belge, Gazanfer, et al.
Publicado: (2020)

Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2021)

Testicular microlithiasis as a familial risk factor for testicular germ cell tumour
por: Coffey, J, et al.
Publicado: (2007)

Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor
por: Belge, Gazanfer, et al.
Publicado: (2020)

Genomic copy number and expression patterns in testicular germ cell tumours
por: McIntyre, A, et al.
Publicado: (2007)

HMGA2 expression distinguishes between different types of postpubertal testicular germ cell tumour
por: Kloth, Lars, et al.
Publicado: (2015)

Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
por: Xu, Y, et al.
Publicado: (2012)

Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
por: Radtke, A., et al.
Publicado: (2017)

The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis
por: Gee, H E, et al.
Publicado: (2011)

Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age—a statistical analysis
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2023)

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2019)

Circulating microRNAs in plasma of patients with gastric cancers
por: Tsujiura, M, et al.
Publicado: (2010)

Systemic immune-inflammation index in germ-cell tumours
por: Chovanec, Michal, et al.
Publicado: (2018)

Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma
por: Konishi, H, et al.
Publicado: (2012)

Involvement of dysadherin and E-cadherin in the development of testicular tumours
por: Batistatou, A, et al.
Publicado: (2005)

Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature
por: Fukumoto, I, et al.
Publicado: (2014)

Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c
por: Nygren, M K, et al.
Publicado: (2014)

Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer
por: Regouc, Manuel, et al.
Publicado: (2020)

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
por: Komatsu, S, et al.
Publicado: (2011)

Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
por: Jones, C I, et al.
Publicado: (2012)

Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression
por: Kornfeld, J-W, et al.
Publicado: (2011)

Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2022)

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
por: Summerer, I, et al.
Publicado: (2015)

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker
por: Goto, Yusuke, et al.
Publicado: (2015)

MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis
por: Silva-Santos, R M, et al.
Publicado: (2013)

MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1
por: Feng, Y, et al.
Publicado: (2014)

Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours
por: Rijlaarsdam, M A, et al.
Publicado: (2011)

Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer
por: Yuan, Zixu, et al.
Publicado: (2017)

The Two Stem Cell MicroRNA Gene Clusters C19MC and miR-371-3 Are Activated by Specific Chromosomal Rearrangements in a Subgroup of Thyroid Adenomas
por: Rippe, Volkhard, et al.
Publicado: (2010)

Activation of the two microRNA clusters C19MC and miR-371-3 does not play prominent role in thyroid cancer
por: Rippe, Volkhard, et al.
Publicado: (2012)

Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer
por: Amir, Sumaira, et al.
Publicado: (2016)

microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients
por: van Agthoven, Ton, et al.
Publicado: (2017)

Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma
por: Nohata, N, et al.
Publicado: (2011)

Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis
por: Carter, Jane V, et al.
Publicado: (2017)

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells
por: Tomimaru, Y, et al.
Publicado: (2010)

Exosome-delivered microRNAs of “chromosome 19 microRNA cluster” as immunomodulators in pregnancy and tumorigenesis
por: Bullerdiek, Jörn, et al.
Publicado: (2012)

Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model
por: Rotkrua, P, et al.
Publicado: (2013)

Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation
por: Hall, J S, et al.
Publicado: (2012)

Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer
por: Miyamae, Mahito, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hoicef7t0ec34q61sogdob275k